170 related articles for article (PubMed ID: 1690236)
1. HIV-1 transmission and function of virus-infected monocytes/macrophages.
Mann DL; Gartner S; Le Sane F; Buchow H; Popovic M
J Immunol; 1990 Mar; 144(6):2152-8. PubMed ID: 1690236
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
3. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
[TBL] [Abstract][Full Text] [Related]
4. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells.
Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS
J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717
[TBL] [Abstract][Full Text] [Related]
5. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
[TBL] [Abstract][Full Text] [Related]
6. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
7. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication.
Francis ML; Meltzer MS
J Immunol; 1993 Aug; 151(4):2208-16. PubMed ID: 8345204
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
9. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons.
Blauvelt A; Clerici M; Lucey DR; Steinberg SM; Yarchoan R; Walker R; Shearer GM; Katz SI
J Immunol; 1995 Apr; 154(7):3506-15. PubMed ID: 7897231
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
[TBL] [Abstract][Full Text] [Related]
11. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
12. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific heterogeneity of the HIV-1 V3 loop in infected individuals: selection of virus in macrophages and plasma.
Yamashita A; Yamamoto N; Matsuda J; Koyanagi Y
Virology; 1994 Oct; 204(1):170-9. PubMed ID: 7916512
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 infection: is it time to reconsider our concepts?
Krambovitis E; Spandidos DA
Int J Mol Med; 2006 Jul; 18(1):3-8. PubMed ID: 16786149
[TBL] [Abstract][Full Text] [Related]
15. Dys-regulation of effector CD4+ T cell function by the V3 domain of the HIV-1 gp120 during antigen presentation.
Zafiropoulos A; Baritaki S; Vlata Z; Spandidos DA; Krambovitis E
Biochem Biophys Res Commun; 2001 Jun; 284(4):875-9. PubMed ID: 11409875
[TBL] [Abstract][Full Text] [Related]
16. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
Capobianchi MR
J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
[TBL] [Abstract][Full Text] [Related]
17. Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro.
Ennen J; Seipp I; Norley SG; Kurth R
Eur J Immunol; 1990 Nov; 20(11):2451-6. PubMed ID: 2253685
[TBL] [Abstract][Full Text] [Related]
18. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
19. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
[TBL] [Abstract][Full Text] [Related]
20. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS
J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
